Mycobacteriology William H. Benjamin, Jr.

Similar documents
Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

MYCOBACTERIA. Pulmonary T.B. (infect bird)

Characteristics of Mycobacterium

AFB Identification Texas Approach

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

CHAPTER 3: DEFINITION OF TERMS

number Done by Corrected by Doctor Hamid Al Zoubi

Communicable Disease Control Manual Chapter 4: Tuberculosis

MYCOBACTERIOLOGY SERVICE MANUAL

Pathology of pulmonary tuberculosis. Dr: Salah Ahmed

MYCOBACTERIUM. Mycobacterium Tuberculosis (Mtb) nontuberculous mycobacteria (NTM) Mycobacterium lepray

Tuberculosis. By: Shefaa Q aqa

ACCME/Disclosures. Two Patients and a Caveat 4/13/2016. Patient #1: 13 y/o boy with IPEX syndrome; s/p BMT

MO TASEM AJ Nader Alaridah

Mycobacterium tuberculosis. Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Fundamentals of Tuberculosis (TB)

Order: Actinomycetales. Family: Mycobactericeae. Some are parasitic to cold blooded animal, others are saprophytic in nature.

Respiratory System الفريق الطبي االكاديمي

Mycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods

Tuberculosis Intensive

Tuberculosis Pathogenesis

TB Intensive San Antonio, Texas December 1-3, 2010

NTM Plus Case Studies

Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis

Nontuberculous Mycobacteria (NTM)

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

TUBERCULOSIS. Famous victims in their intellectual prime: Chopin, Paganini, Thoreau, Keats, Elizabeth Browning, Brontës

Contracts Carla Chee, MHS May 8, 2012

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing

Tuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH)

MODULE ONE" TB Basic Science" Treatment Action Group TB/HIV Advocacy Toolkit

Stacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona

Tuberculosis Elimination: The Role of the Infection Preventionist

TB Laboratory for Nurses

Tuberculosis Tools: A Clinical Update

Transmission and Pathogenesis of Tuberculosis. Transmission and Pathogenesis of Tuberculosis. Mycobacteria. Introduction to the pathogen Transmission

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Transmission and Pathogenesis of Tuberculosis

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW.

Leprosy. Dr Rodney Itaki Lecturer Anatomical Pathology Discipline

TB Updates for the Physician Rochester, Minnesota June 19, 2009

What is it? Sherlock knows! Mycobacteria Identification System

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Variety of Names. Great White Plague

Mycobacterial Infections in HIV. H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine

General Infectious Diseases

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

HIDDEN IN PLAIN SITE:

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Tuberculosis: The Essentials

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Tuberculosis Pathophysiology and Transmission

Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

SWABCHA Fact Sheet: Tuberculosis (TB)

2018 Vindico Medical Education. Non-tuberculous Mycobacteria: Circumventing Difficulties in Diagnosis and Treatment

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Tuberculosis Part 1. Some useful truths

TB 101 Disease, Clinical Assessment and Lab Testing

9 month old with stridor, cough, low-grade fever, mild hypoxia

Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018

Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis

7. BCG Vaccination HSE/HPSC. Guidelines on the Prevention and Control of Tuberculosis in Ireland IUATLD criteria

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Diagnosis and Medical Management of Latent TB Infection

TUBERCULOSIS. Pathogenesis and Transmission

2/18/19. Case 1. Question

DOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI

Transmission of Mycobacterium tuberculosis

Nontuberculous Mycobacterial Lung Disease

At the end of this session, participants will be able to:

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

TB Intensive Houston, Texas October 15-17, 2013

Making the Diagnosis of Tuberculosis

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018

The Air We Share: Principles and Practices of TB Infection Control

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Objectives. TB Laboratory Methods

BCG in Tower Hamlets. Luise Dawson Public Health Nurse

(A) Consumption of contaminated food (B) Direct contact with fomite (C) Arthropod vector (D) Respiratory route (E) Sexual contact

TUBERCULOSIS. By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi

Ken Jost, BA, has the following disclosures to make:

Role of the Laboratory in TB Diagnosis and Management

Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?

General Session IV - Dale Schwab April 20, 2017

TB Intensive San Antonio, Texas November 11 14, 2014

Chapter 22. Pulmonary Infections

Self-Study Modules on Tuberculosis

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria

56% of these were in south east Asia and west pacific region.

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

Transcription:

Mycobacteriology William H. Benjamin, Jr. William H. Benjamin, PhD Department of Pathology UAB 1 Mycobacteria sp. Acid Fast Bacilli (AFB) Mycolic acids (C78-91) Waxes Obligate aerobes Slow growing days to weeks to form colonies 18 hour doubling time for M. tuberculosis 2 1

Identification of Acid Fast Bacilli Mycobacterium sp. - are identified by the acid fast stain Mycobacteria predate animal life 100 named Mycobacterial species More than 40 have infected humans AIDS other immunocompromised 3 4 2

Obligate Pathogenic Mycobacteria Mycobacterium tuberculosis First bacteria shown to cause disease 1882 Koch s postulates M. leprae causes Hansen s disease or leprosy 5 Mycobacterium tuberculosis Humans are the only natural host 1/3 of the world population is infected 9.2 million cases of tuberculosis/year disease 1.7 million deaths caused by tuberculosis/year 6 3

Prehistory of Tuberculosis 17,000 BPE (before present era) bison in Wyoming USA IS6110 and Spoligotype confirmed M. tuberculosis 10,000 BPE in Germany skeletal evidence 3500-3000 BPE Egypt Potts disease PCR positive for Mtb sequence 1300 BPE 8 year old Inca boy Pott s disease, AFB smear positive, IS6110 PCR positive 7 8 4

Tuberculosis in the United States 30,000 Cases Deaths 25,000 20,000 15,000 13,299 10,000 5,000 646 0 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 U. S. Tuberculosis Cases 20,000 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 U. S. Born Foreign Born 2.7 23.6 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 10 5

11 625 575 525 475 425 375 325 275 225 544 588 541 524 Alabama Tuberculosis Cases 464 484 430 418 487 433 420 423 405 380 318 314 265 258 233 211 216 196 175 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 12 6

Examples of high prevalence countries Namibia Zambia US Population (million) 1.8 11.5 300 Tuberculosis cases 16,156 78,000 13,676 Tuberculosis rate/100,000 822 680 4.2 Tuberculosis death rate 61? 0.22 13 Transmission of Tuberculosis Transmission is by infectious droplet droplet diameter 1-5 µm droplet contains 1-3 bacilli droplets settle 9 mm/min in still air infectious dose is 5-200 infectious droplets average patient exhales 1.25 infectious droplets/hour some cases produce 150-200 infectious droplets/hour 7

Exposure close contact No infection >50% Infection 50% Primary active TB 5% Latent TB 95% Never reactivate 90% Reactivation TB 5% lifetime HIV+ 5-10% per year 15 Tuberculosis Risk Factors AIDS - CD 4 < 400 Iatrogenic immunosuppression - corticosteroids Age young old Alcoholism/malnourishment Diabetes Genetics 8

Mantoux skin test mm of induration 17 Significant Induration on Mantoux 15 mm Always indicates infection 10 mm population at risk low income, minority races, IV drug users foreign born - from high prevalence countries Institution populations - prisons, nursing homes, mental institutions silicosis, diabetes mellitus, malignancies, immunosuppressive agents 5 mm Early, immunosuppressed HIV positive or HIV risk factors HIV status unknown Chest film consistent with old nonreactive tuberculosis Recent close contact with infectious tuberculosis case 18 9

Types of Tuberculous disease Childhood tuberculosis Adult or reactivation disease Acute tuberculous pneumonia (AIDS) Miliary tuberculosis Cold abscess Addison s disease (Adrenal insufficiency) Types of Disease caused by M. tuberculosis 20 10

M. tuberculosis infection without disease Inhalation of infectious droplet Hilar and peribronchiolar lymph nodes 4-6 weeks Lymphohematogenous dissemination 6-8 weeks Tubercle formation Granulomatous inflammation: caseous necrosis Dystrophic calcification (Ghon complex) Diagnosis of Tuberculosis AFB smear Tuberculin skin test (Mantoux test) Chest radiograph AFB culture 11

Tuberculosis prevention Environmental - decrease exposure Avoid crowded conditions Air changes UV irradiation Chemoprophylaxis after positive skin test INH - after Tuberculin skin test conversion 6 months of daily oral INH BCG vaccine (Bacille-Calmette-Guerin) Causes positive skin test Used in much of the world, except US M. tuberculosis direct smear 24 12

Environmental Resistance of M. tuberculosis Survives drying Susceptible to UV irradiation (2 hours in sunlight) Resistant to many disinfectants susceptible to chlorine and phenols Pasteurization kills (62 o C 30 min or 71.7 o C 15 sec) HEPA filters 25 Germicidal Ultraviolet Light UV light at 254 nm is effective in killing infectious agents In air ducts In upper room irradiation Also used in biological safety cabinets Demonstration of effectiveness of killing M. tuberculosis on Middlebrook 7H11 plate 26 13

UV Exposed Culture Plate 0 min 1 min 27 AFB Cultures at UAB total Positive Positive cultures cultures for Mtb 1988 2637 80 (3.0%) 42 (1.6%) 1989 2698 76 (2.8%) 23 (0.9%) 1990 2848 126 (4.4%) 24 (0.8%) 1991 2931 120 (4.1%) 23 (0.8%) 1992 3226 145 (4.5%) 35 (1.1%) 1993 3418 177 (5.2%) 39 (1.1%) 1994 4330 259 (5.9%) 89 (2.1%) 1995 4126 219 (5.3%) 98 (2.4%) 1996 3970 224 (5.6%) 82 (2.1%) 1997 4389 308 (7.0%) 114 (2.7%) 1998 5234 293 (5.6%) 77 (1.5%) 1999 4984 256 (5.1%) 73 (1.5%) 2000 4932 278 (5.6%) 99 (2.0%) 2001 5609 271 (4.8%) 69 (1.2%) 2002 5228 223 (4.2%) 50 (1%) 2003 4626 275 (5.9%) 57 (1.2%) 2004 4025 252 (6.2%) 29 (0.7%) 2005 3972 230 5.8%) 31 (0.8% 2006 4742 248 (5.2%) 38 (0.8%) 28 14

Diagnostic M. tuberculosis Cultures 1999 2000 2001 2002 2003 2004 2005 Patients 32 40 24 16 15 10 15 Days to growth 13.6 15.5 16 14 17.6 20 17 Days to Identification AFB positive Respiratory Positive AFB M. tuberculosis 16.8 19.8 21.3 17 21 30 20 17/28 60% 17/35 48% 20/28 71% 20/31 65% 14/20 70% 14/34 41% 12/15 80% 12/28 43% 7/12 58% 7/29 24% 5/7 71% 5/22 23% 6/11 55% 6/18 33% 29 Number of Patients Each Species of Mycobacteria Were Isolated from at UAB 1990 to 2007 M. avium cx M. tuberculosis M. fortuitum M. kansasii M. abscessus Rapid pigmented M. xenopi M. lentiflavum M. marinum M. scrofulaceum M. mucogenicum 771 441 391 132 115 19 18 18 13 12 8 M. szulgai M. gastri M. brumae M. triplex M. austroafricanum M. smegmatis M. flavescens M. haemophilum M. thermoresistable M. peregrinum M. simiae 30 5 3 3 3 2 2 1 1 1 1 1 15

M. tuberculosis concentrated smear 31 Microbiological Diagnosis of Tuberculosis Digestion - mucolytic agents Decontamination Concentration Acid fast Stain Cultivation of Mycobacteria solid media liquid culture Anti-Mycobacterial susceptibilities 32 16

33 Decontamination and Concentration of AFB Cultures Mucolytic agent (N-acetyl-L-cysteine) 2% NaOH 1% oxalic acid Centrifuge 3000 x g for 30 min. 34 17

Mycobacteria Culture Media Solid media - 21-26 days to detection Loewenstein-Jensen (egg based) Middlebrook 7H11 (agar based) Liquid media - 8 to 14 days to detection BACTEC 460 ( 14 CO 2 release from 14 C palmitic acid) MB/BacT (CO 2 production) ESP (O 2 utilization - pressure change) MIDGIT (O 2 utilization - quenching of fluorescence) 35 Colony Morphology of M. gordonae and M. tuberculosis 36 18

Liquid Culture Systems VersaTREK Mycobacteria MGIT BD MB/BacT 37 Growth in Liquid Medium: M. tuberculosis and M. fortuitum 38 19

M. tuberculosis cords in liquid culture 39 Mycobacterium abscessus direct sputum smear 40 20

Gram Stain of M. tuberculosis cords 41 M. Kansasii concentrated smear 42 21

Identification of Mycobacteria Biochemical tests 2 to 3 weeks GenProbe - DNA - RNA hybridization 2 hours HPLC - high performance liquid chromatography 1 hour 43 Hybridization Protection Assay (GenProbe) Denatured (heat) Acridinium-labeled probe Alkaline hydrolysis Inactivated probe Substrate light 44 22

Mycobacterium avium complex (MAC) found in soil and water - tap water transmission through either respiratory or GI tract pulmonary disease like tuberculosis disseminated disease in AIDS patients 50% of autopsies resistant to many anti-mycobacterial drugs slow growing non-pigmented colonies Other Important MOTT M. kansasii - Photochromogen Tuberculosis like disease M. marinum - Photochromogen Found in water - fish tanks and surface water 30 to 33 o C optimum temperature M. scrofulaceum - granulomatous cervical lymphadenitis in children M. fortuitum - M. chelonei complex Rapid growers - colonies in less than 7 days Skin infections, pulmonary disease 23

M. marinum lymphocutaneous 47 M. marinum Fresh or salt water or no water exposure Photochromogen 1-2 patients/year at UAB 9 finger patients 30 o C optimum temperature colonies form in 10-14 days 48 24

Mycobacterium leprae Hansen s disease humans and armadillos are the only natural hosts 12 million cases worldwide 6,000 registered cases in US, 112-350 cases/year transmitted by inhalation or skin contact with contaminated respiratory secretions of lepromatous patients incubation period is 3 months to 3 years 50 25

Clinical Types of Leprosy Tuberculoid leprosy intact cell mediated response to M. leprae organisms rare in tissue organisms grow in nerves in cooler parts of the body cutaneous loss of sensation - nerve damage due to cell mediated immunity diagnosis Leprosy does not grow on artificial media will grow in nude mice or armadillo AFB stain of nasal secretions lepromin test - skin test treatment dapsone and rifampicin - at least 1 year prevention isolation of acute lepromatous cases vaccines under development 26

Lepromatous Leprosy depressed CMI response specific for M. leprae bacteremia with localization in nerves and skin high numbers of organisms in macrophages less loss of nerve function leonine facies other organs involved - testes, spleen and liver Lepromatous leprosy 54 27

Tuberculoid leprosy Non-progressive disease intact cell mediated response organisms rare in tissue macular lesions predominate organisms invade nerves and form granulomas cutaneous loss of sensation - nerve damage due to CMI 55 Tuberculous leprosy 56 28